@misc{indiciae08967b52786b,
  title = {Sustained efficacy of CRISPR-Cas13b gene therapy for FSHD is challenged by immune response to Cas13b},
  author = {Rashnonejad, A. and Farea, M. and Chermahini, G. A. and COULIS, G. and Taylor, N. and Fowler, A. and Villalta, A. and King, O. D. and Harper, S. Q.},
  year = {2025},
  doi = {10.1101/2024.12.18.629250},
  url = {https://www.biorxiv.org/content/10.1101/2024.12.18.629250v1},
  note = {Source identifier: 10.1101/2024.12.18.629250}
}